Clinically Localized Prostate Cancer: Introduction, Risk Assessment, Staging and Risk-Based Management

Publication Date: May 10, 2022
Last Updated: May 11, 2022

Risk Assessment

Clinicians should use clinical T stage, serum PSA, Grade Group (Gleason score), and tumor volume on biopsy to risk stratify patients with newly diagnosed prostate cancer. (Strong, B)
322859

Staging

Clinicians should not routinely perform abdomino-pelvic computed tomography (CT) scan or bone scan in asymptomatic patients with low- or intermediate-risk prostate cancer. (Expert Opinion, )
322859

Overview

Title

Clinically Localized Prostate Cancer: Introduction, Risk Assessment, Staging and Risk-Based Management

Authoring Organizations